Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/1998
08/06/1998WO1998033768A1 Arylsulfonylamino hydroxamic acid derivatives
08/06/1998WO1998033524A1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
08/06/1998WO1998033509A2 Useful properties of human lactoferrin and variants thereof
08/06/1998WO1998033508A1 Calcareous material
08/06/1998WO1998024763A3 Immunotherapeutic imides/amides as pde iv and tnf inhibitors
08/06/1998WO1998021332A3 Secreted proteins and polynucleotides encoding them
08/06/1998WO1998002148A3 Pharmaceutical composition
08/06/1998CA2851502A1 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
08/06/1998CA2279594A1 Calcareous material
08/06/1998CA2279344A1 Human c5a-like receptor
08/06/1998CA2278638A1 Peptides comprising a t-cell epitope specific to collagen ii
08/06/1998CA2278595A1 Secreted proteins and polynucleotides encoding them
08/06/1998CA2222981A1 Promoter of the human endoglin gene and its use
08/05/1998EP0856520A1 Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
08/05/1998EP0856513A2 Thalidomide analogues from the piperidine-2,6-dione class
08/05/1998EP0856007A1 Cyclopeptide derivatives
08/05/1998EP0856000A1 1,3,5-trisubstituted pyrazoles for treament of inflammation
08/05/1998EP0855914A1 Stable formulations of mhc-peptide complexes
08/05/1998EP0752990B1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
08/05/1998EP0690872B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
08/05/1998EP0674505B1 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails
08/05/1998CN1189832A Diazepino-indoles as phosphodiesterase IV inhibitors
08/05/1998CN1189829A Piperazino derivatives as neurokinin antagonists
08/05/1998CN1189823A Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/05/1998CN1189821A Substituted oximes, hydrazones and olefins as neurokinin antagonists
08/05/1998CN1189491A Isoxazole and crotonamide derivatives and their use as pharmaceuticals and disgnositics
08/05/1998CN1189337A Novel therapeutic anti-inflammatory and analgesic composition containing nimesulide for use transdermally and process for manufature thereof
08/05/1998CN1189336A Novel therapeutic injectable analgesic composition containing nimesulide and process for manufacture thereof
08/05/1998CA2221687A1 Tumor necrosis related receptor, tr5
08/04/1998US5789573 Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
08/04/1998US5789447 Nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/04/1998US5789406 Indeno 1,2-E!pyrazine-4-ones, their preparation and the medicaments containing them
08/04/1998US5789395 Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
08/04/1998CA2149242C Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders
08/03/1998CA2220852A1 Tumor necrosis related receptor, tr4
08/01/1998CA2228385A1 Compounds analogous to thalidomide from the class comprising piperdine-2,6-diones
07/1998
07/30/1998WO1998032863A2 Mammalian thioredoxin
07/30/1998WO1998032766A1 SUBSTITUTED AMINO BICYCLIC-β-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
07/30/1998WO1998032748A1 Sulfamide-metalloprotease inhibitors
07/30/1998WO1998032734A1 SUBSTITUTED β-THIOCARBOXYLIC ACIDS
07/30/1998WO1998032733A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
07/30/1998WO1998032732A1 5-aroylnaphthalene derivatives
07/30/1998WO1998032730A1 Aminobenzophenones as inhibitors of interleukin and tnf
07/30/1998WO1998032718A1 New fatty acid derivatives
07/30/1998WO1998032452A1 Treatment of chronic inflammatory diseases with cm101/gbs toxin
07/30/1998WO1998032451A1 Treatment of autoimmune disease using tolerization in combination with methotrexate
07/30/1998WO1998027108A3 New amide compounds and their use as nitric oxide synthase inhibitors
07/30/1998WO1998024780A3 Substituted pyrimidinone and pyridinone compounds and their use
07/30/1998WO1998023565A3 Aminoguanidines and alkoxyguanidines as protease inhibitors
07/30/1998WO1998021237A3 Peptide compounds useful for modulating FGF receptor activity
07/30/1998DE19803003A1 5-Aroylnaphthalinderivate 5-Aroylnaphthalinderivate
07/30/1998DE19802350A1 Sulfamid-Metalloprotease-Inhibitoren Sulfamide metalloprotease inhibitors
07/30/1998CA2279241A1 Mammalian thioredoxin
07/30/1998CA2278779A1 Substituted amino bicyclic-.beta.-lactam penam and cepham derivatives as cysteine protease inhibitors
07/30/1998CA2278152A1 Treatment of autoimmune disease using tolerization in combination with methotrexate
07/30/1998CA2228017A1 A drug preparation for oral administration
07/29/1998EP0854885A1 Recombinant anti-cd4 antibodies for human therapy
07/29/1998EP0854870A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity
07/29/1998EP0854863A1 Esters and amides as pla2 inhibitors
07/29/1998EP0854860A1 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same
07/29/1998EP0854723A1 Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies as antiinflammatory agents
07/29/1998EP0854720A1 Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy
07/29/1998EP0854710A2 USE OF A $g(g)-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE
07/29/1998EP0749428B1 Isoxazoline compounds as inhibitors of tnf release
07/29/1998EP0740668B1 Tetracyclic derivatives, process of preparation and use
07/29/1998EP0722434B1 Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
07/29/1998EP0681571B1 Spiro-substituted azacycles as tachykinin receptor antagonists
07/29/1998EP0580650B1 Novel 2-spirocyclopropyl 4-acylcephems and processes for the preparation thereof
07/29/1998CN1189166A Somatostatin peptides
07/29/1998CN1189156A Quinoline derivatives containing a diol as leukotriene antagonists
07/29/1998CN1189105A Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagenosis
07/29/1998CN1039329C Process for preparing steroid esters compound
07/29/1998CN1039327C Novel thio-substituted nitrogen-containing heterocyclic phosphonate compounds, pharmaceutical compositions and pharmacy application
07/29/1998CN1039317C Substituted benzoate derivatives
07/28/1998US5786379 Adamantyl-substituted biaromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
07/28/1998US5786347 Vitamin D amine and amide derivatives
07/28/1998US5786197 lep
07/28/1998US5785993 Reduction of adhesions using controlled delivery of active oxygen inhibitors
07/23/1998WO1998031802A2 Secreted proteins and polynucleotides encoding them
07/23/1998WO1998031709A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
07/23/1998WO1998031704A2 Tachykinin antagonists
07/23/1998WO1998031674A1 Phthalazinones
07/23/1998WO1998031663A1 Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing said compound
07/23/1998WO1998031359A1 Integrin antagonists
07/23/1998WO1998031343A2 Aqueous suspension for nasal administration of loteprednol
07/23/1998WO1998031227A1 Novel cannabinoid receptor modulators
07/23/1998DE19701694A1 Neue Modifikationen des 2-Amino-4-(4-fluorbenzylamino)-l-ethoxycarbonyl-aminobenzen sowie Verfahren zu ihrer Herstellung Recent modifications of 2-amino-4- (4-fluorobenzylamino) -l-ethoxycarbonyl-diaminobenzene as well as processes for their preparation
07/23/1998DE19701607A1 Anitkörper, die an die Nidogen-Bindungsdomäne des Laminins binden, deren Herstellung und Verwendung Anitkörper that bind to the nidogen-binding domain of laminin, their preparation and use
07/23/1998CA2278477A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
07/23/1998CA2278307A1 Novel cannabinoid receptor modulators
07/23/1998CA2278153A1 Secreted proteins and polynucleotides encoding them
07/22/1998EP0854145A2 Vitronectin receptor antagonists, their production and their use
07/22/1998EP0854140A2 Vitronectin receptor antagonists, their production and their use
07/22/1998EP0853943A1 Antiallergic agent
07/22/1998EP0853673A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE
07/22/1998EP0853661A1 Specific binding members for human transforming growth factor beta; materials and methods
07/22/1998EP0853626A1 Substituted phosphinic compounds and their use as pharmaceuticals
07/22/1998EP0853478A1 New n-acylated 4-hydroxyphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them
07/22/1998EP0748312B1 Bicyclic carbamates as leukotriene d4 antagonists
07/22/1998EP0486561B2 Buccal composition containing s(+) ketoprofen